SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

27 May 2026 Evaluate
The sales for the March 2026 quarter moved down to Rs. 1098.76 millions as compared to Rs. 1220.38 millions during the year-ago period.Net profit declined -26.40% to Rs. 215.73 millions from Rs. 293.12 millions.The Operating Profit of the company witnessed a decrease to 279.37 millions from 365.57 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1098.76 1220.38 -9.97 4502.53 4305.32 4.58 4502.53 4305.32 4.58
Other Income 60.99 38.83 57.07 238.99 116.78 104.65 238.99 116.78 104.65
PBIDT 279.37 365.57 -23.58 1146.96 1117.93 2.60 1146.96 1117.93 2.60
Interest 27.66 29.90 -7.49 114.84 141.99 -19.12 114.84 141.99 -19.12
PBDT 342.42 335.67 2.01 1101.78 975.94 12.89 1101.78 975.94 12.89
Depreciation 50.82 55.97 -9.20 209.36 231.73 -9.65 209.36 231.73 -9.65
PBT 291.60 279.70 4.25 892.42 744.21 19.92 892.42 744.21 19.92
TAX 75.87 -13.42 -665.35 249.58 68.05 266.76 249.58 68.05 266.76
Deferred Tax 38.12 -63.17 -160.35 103.50 -63.17 -263.84 103.50 -63.17 -263.84
PAT 215.73 293.12 -26.40 642.84 676.16 -4.93 642.84 676.16 -4.93
Equity 143.35 145.84 -1.71 143.35 145.84 -1.71 143.35 145.84 -1.71
PBIDTM(%) 25.43 29.96 -15.12 25.47 25.97 -1.90 25.47 25.97 -1.90

Fermenta Biotech Share Price

330.90 11.35 (3.55%)
05-Jun-2026 10:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.25
Dr. Reddys Lab 1272.50
Cipla 1391.10
Zydus Lifesciences 1091.00
Lupin 2277.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×